PREVENTING AND MANAGING HYPOTENSION

被引:65
作者
DAUGIRDAS, JT
机构
[1] University of Illinois College of Medicine, West Side Veterans Affairs Hospital, Chicago, Illinois
关键词
D O I
10.1111/j.1525-139X.1994.tb00786.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Simple maneuvers to prevent dialysis hypotension include measures to help maintain blood volume and to limit interdialytic weight gain. After several years of development, the use of hematocrit sensors and intelligent feedback regulation of the ultrafiltration rate based on blood volume, on-line measurement of cardiac output, or blood pressure, will soon be a reality. The use of acetate is fast becoming obsolete in the United States, because acetate has a number of adverse effects on the cardiovascular system. A preliminary report that acetate dialysis is associated with better solute removal from the body needs to be confirmed. Wider use of cool temperature dialysis is limited by frequent patient discomfort (feeling cold, shivering), and cool dialysis may adversely affect urea removal during dialysis, though this needs to be studied. In patients who experience sudden episodes of hypotension during dialysis, the mechanism may be sudden withdrawal of sympathetic tone. This may be related to generation of adenosine due to tissue ischemia. A rational approach to this type of patient would be to minimize tissue ischemia by increasing the baseline hematocrit if low, and by giving nasal oxygen during the treatment. Predialysis nasal administration of lysine vasopressin may help some patients with refractory dialysis hypotension.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 77 条
[61]  
Shimoyama H, Suwata J, Saitoh H, Oguchi K., Kobayashi S, Kawada Y, Changes in catecholamine level in hypotensive patients subjected to dialysis, Nippon Jinzo Gakkai Shi, 31, pp. 165-170, (1989)
[62]  
Lindberg JS, Copley JB, Melton K, Wade CE, Abrams J., Goode D, Lysine vasopressin in the treatment of refractory hemodialysis induced hypotension, Am J Nephrol, 10, pp. 269-275, (1990)
[63]  
Ahmad S., Robertson HT, Golper TA, Wolfson M., Kurtin P., Katz LA, Hirschberg R, Nicora R., Ashbrook DW, Kopple JD, Multicenter trial of L‐carnitine in maintenance hemodialysis patients. 11. Clinical and biochemical effects, Kidney Int, 38, pp. 912-918, (1990)
[64]  
Converse RL, Jacobsen TN, Jost CM, Toto RD, Grayburn PA, Obregon TM, Fouad-Tarazi F, Victor RG, Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis‐induced hypotension, J Clin Invest, 90, pp. 1657-1665, (1992)
[65]  
Salem M., Ivanovich PT, Ing TS, Daugirdas JT
[66]  
Keshaviah P, Carlson L, Constantini E, Shapiro F, Dialysis‐induced hypoxemia and hypotension are not causally related, ASAIO Trans, 30, pp. 159-162, (1984)
[67]  
Fijiwam Y, Hagthara B., Yamauchi A, Shirai D, Hypoxemia and hemodialysis‐induced symptomatic hypotension, Clin Nephrol, 24, pp. 9-14, (1985)
[68]  
Nielsen AL, Brinkenfeldt H., Thunedborg P, Hegbrandt J, Jensen HE, Critical oxygen concentration during hemodialysis. (abstract), J Am Soc Nephrol, 4, (1993)
[69]  
Gong R, Lindberg J, Abrams J., Whitaker WR, Wade CE, Gouge S, Comparison of hypertonic saline solutions and dextran in dialysis‐induced hypotension, J Am Soc Nephrol, 3, pp. 1808-1812, (1993)
[70]  
Engel A, Adler OB, Loberant N, Rosenberger A, Wiessman I., Nonocclusive ischaemic bowel disease in patients on chronic haemodialysis, ROFO Fortschr Geb Rontgenstr Nuklearmed, 150, pp. 704-707, (1994)